Watch Demo

Serbia Pharmaceutical Industry Outlook 2022 - 2026

See how Serbia Pharmaceutical performed compared to key markets such as Switzerland, Italy and Spain.

Key Market Indicators

Serbian pharmaceutical production is expected to reach €6.18 million by 2026. This is a 3.2% average annual growth rate from 2021's €5.17 million. Serbia placed 17th in the 2021 rankings, with Finland overtaking it with €5.17 million. Italy, Spain and Austria held the top three spots in the rankings.

Marketing Banner

Serbia Pharmaceutical Market Data and Forecasts

Improve your Knowledge with the latest Indicators and Trends